Functional Ultrasound Imaging Combined with Machine Learning for Whole-Brain Analysis of Drug-Induced Hemodynamic Changes
Functional ultrasound imaging (fUSI) is a cutting-edge technology that measures changes in cerebral blood volume (CBV) by detecting backscattered echoes from red blood cells moving within its field of view (FOV). It offers high spatiotemporal resolution and sensitivity, allowing for detailed visualization of cerebral blood flow dynamics. While fUSI has been utilized in preclinical drug development studies to explore the mechanisms of action of various drugs targeting the central nervous system, many of these studies rely on predetermined regions of interest (ROIs). This focus may overlook relevant brain activity outside these specific areas, which could influence the results. To address this limitation, we compared three machine learning approaches-convolutional neural network (CNN), support vector machine (SVM), and vision transformer (ViT)-combined with fUSI to analyze the pharmacodynamics of Dizocilpine (MK-801), a potent non-competitive NMDA receptor antagonist commonly used in preclinical models for memory and learning impairments. While all three machine learning techniques could distinguish between drug and control conditions, CNN proved particularly effective due to their ability to capture hierarchical spatial features while maintaining anatomical specificity. Class activation mapping revealed brain regions, including the prefrontal cortex and hippocampus, that are significantly affected by drug administration, consistent with the literature reporting a high density of NMDA receptors in these areas. Overall, the combination of fUSI and CNN creates a novel analytical framework for examining pharmacological mechanisms, allowing for data-driven identification and regional mapping of drug effects while preserving anatomical context and physiological relevance.